Cutaneous Carcinoma: Identifying Skin Cancer and Treatments
-
Register
- User - $10
Skin cancer is the most common cancer diagnosed in the United States and primary care providers are often the first to screen and detect these. Through a combination of case studies and photos, attendees will be able to identify the numerous skin cancers (actinic keratosis, squamous cell, basal cell, dysplastic nevi, and malignant melanoma) as well as determine the appropriate treatment plans.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.00 contact hours; 0.25 are pharmacology
Expiration Date: June 30th, 2025
$10.00
LEARNING OBJECTIVES
As a result of this activity, learners will be able to:
- Identify actinic keratosis and squamous cell cancer and determine an appropriate treatment plan
- Identify basal cell cancer and determine an appropriate treatment plan
- Identify dysplastic nevi and malignant melanoma and determine an appropriate treatment plan
Kathleen E. Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP
Dermatology Nurse Practitioner at Riverside Dermatology
Dr. Kathleen Haycraft is a family, pediatric and dermatology nurse practitioner. Kathleen is a published author of numerous books and journals. She has served as a national speaker at dermatology conferences and on dermatology content for general conferences. Dr. Haycraft represents Region 7 on the American Association of Nurse Practitioners and has written and spoke on topics regarding health policy. Kathleen has served on advisory boards for education and health care in her state of Missouri. She has been employed as an educator, administrator but is currently working full time in a comprehensive dermatology practice. Dr. Haycraft is faculty for Maui Dermatology whose conferences occur twice a year and is a multidisciplinary faculty of dermatology nurse practitioners, physician assistants and dermatologists.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, you must complete all course components in the following order: 1) complete a three-question pre-test; 2) watch the course presentation video; 3) complete the course evaluation; 4) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your “My Courses/Certificates” --> "Transcripts/Certificates Earned" for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.00 contact hours, of which 0.25 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP, have disclosed the following relevant financial relationships; Author/Advisor for OrthoDerm, Sun and Celgene.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
